← Back to Search

Cetaphil for Psoriasis

Phase 4
Waitlist Available
Led By George F Hougeir, MD
Research Sponsored by Galderma R&D
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up week 2, week 4, week 8
Awards & highlights

Summary

"This trial will test the effectiveness of a skincare regimen for people with plaque psoriasis by having them apply the treatment to one side of their body. Researchers will evaluate the results after 2 weeks,

Who is the study for?
This trial is for individuals with mild-to-severe plaque psoriasis who are currently using or starting a prescription treatment. Participants will apply a topical skincare regimen to one side of their body.Check my eligibility
What is being tested?
The study tests the effectiveness and tolerability of Cetaphil as a skincare product on patients with plaque psoriasis. The efficacy is evaluated at intervals over an 8-week period.See study design
What are the potential side effects?
While not explicitly stated, typical side effects from topical products like Cetaphil may include skin irritation, redness, itching, or allergic reactions.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~week 2, week 4, week 8
This trial's timeline: 3 weeks for screening, Varies for treatment, and week 2, week 4, week 8 for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Change in psoriatic Body Surface Area compared to baseline
Change in skin quality measured by macroscopic imaging
Change in target lesion severity compared to baseline
+3 more
Secondary outcome measures
Subject Quality of Life Satisfaction

Trial Design

1Treatment groups
Experimental Treatment
Group I: Skincare Product TreatmentExperimental Treatment1 Intervention
Subjects will use topical skincare products to assigned side of the body, per randomization.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Cetaphil
2014
Completed Phase 4
~80

Find a Location

Who is running the clinical trial?

Galderma R&DLead Sponsor
300 Previous Clinical Trials
60,414 Total Patients Enrolled
18 Trials studying Psoriasis
4,312 Patients Enrolled for Psoriasis
George F Hougeir, MDPrincipal InvestigatorSoutheast Dermatology Specialist, LLC
Zoe D Draelos, MDPrincipal InvestigatorDermatology Consulting Services, High Point NC
6 Previous Clinical Trials
299 Total Patients Enrolled
1 Trials studying Psoriasis
20 Patients Enrolled for Psoriasis
~0 spots leftby Jul 2024